Literature DB >> 10573240

Development and validation of a questionnaire to measure asthma control.

E F Juniper1, P M O'Byrne, G H Guyatt, P J Ferrie, D R King.   

Abstract

International guidelines on asthma management indicate that the primary goal of treatment should be optimum asthma control. The aim of this study was to develop and validate the Asthma Control Questionnaire (ACQ). The authors generated a list of all symptoms used to assess control and sent it to 100 asthma clinicians who were members of guidelines committees (18 countries). They scored each symptom for its importance in evaluating asthma control. From the 91 responses, the five highest scoring symptoms were selected for the ACQ. In addition, there is one question on beta2-agonist use and another on airway calibre (total questions=7). The ACQ was tested in a 9-week observational study of 50 adults with symptomatic asthma. The ACQ and other measures of asthma health status were assessed at baseline, 1, 5 and 9 weeks. In patients whose asthma was stable between clinic visits, reliability of the ACQ was high (intraclass correlation coefficient (ICC)=0.90). The questionnaire was very responsive to change in asthma control (p<0.0001). Cross-sectional and longitudinal validity were supported by correlations between the ACQ and other measures of asthma health status being close to a priori predictions. In conclusion, the Asthma Control Questionnaire has strong evaluative and discriminative properties and can be used with confidence to measure asthma control.

Entities:  

Mesh:

Year:  1999        PMID: 10573240     DOI: 10.1034/j.1399-3003.1999.14d29.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  549 in total

1.  A trial of clarithromycin for the treatment of suboptimally controlled asthma.

Authors:  E Rand Sutherland; Tonya S King; Nikolina Icitovic; Bill T Ameredes; Eugene Bleecker; Homer A Boushey; William J Calhoun; Mario Castro; Reuben M Cherniack; Vernon M Chinchilli; Timothy J Craig; Loren Denlinger; Emily A DiMango; John V Fahy; Elliot Israel; Nizar Jarjour; Monica Kraft; Stephen C Lazarus; Robert F Lemanske; Stephen P Peters; Joe Ramsdell; Christine A Sorkness; Stanley J Szefler; Michael J Walter; Stephen I Wasserman; Michael E Wechsler; Hong Wei Chu; Richard J Martin
Journal:  J Allergy Clin Immunol       Date:  2010-10       Impact factor: 10.793

2.  Feasibility and acceptability of using bronchial hyperresponsiveness to manage asthma in primary care: a pilot study.

Authors:  James A Turton; Nicholas J Glasgow; John D Brannan
Journal:  Prim Care Respir J       Date:  2012-03

3.  Validation of the English version of the Asthma Quality of Life Questionnaire in a multi-ethnic Asian population.

Authors:  Wan C Tan; Justina W L Tan; Eric W L Wee; Matthew Niti; Tze P Ng
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

Review 4.  Effects of regular exercise on adult asthma.

Authors:  Sirpa A M Heikkinen; Reginald Quansah; Jouni J K Jaakkola; Maritta S Jaakkola
Journal:  Eur J Epidemiol       Date:  2012-04-25       Impact factor: 8.082

5.  [Treatment strategies for asthma].

Authors:  S Korn; C Taube; R Buhl
Journal:  Internist (Berl)       Date:  2012-04       Impact factor: 0.743

6.  Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.

Authors:  Michael E Wechsler; Praveen Akuthota; David Jayne; Paneez Khoury; Amy Klion; Carol A Langford; Peter A Merkel; Frank Moosig; Ulrich Specks; Maria C Cid; Raashid Luqmani; Judith Brown; Stephen Mallett; Richard Philipson; Steve W Yancey; Jonathan Steinfeld; Peter F Weller; Gerald J Gleich
Journal:  N Engl J Med       Date:  2017-05-18       Impact factor: 91.245

7.  Methacholine PC20 in African Americans and whites with asthma with homozygous genotypes at ADRB2 codon 16.

Authors:  Kathryn Blake; James D Cury; Jobayer Hossain; Kelan Tantisira; Jianwei Wang; Edward Mougey; John Lima
Journal:  Pulm Pharmacol Ther       Date:  2013-02-04       Impact factor: 3.410

Review 8.  Bronchial thermoplasty for moderate or severe persistent asthma in adults.

Authors:  Alfons Torrego; Ivan Solà; Ana Maria Munoz; Marta Roqué I Figuls; Juan Jose Yepes-Nuñez; Pablo Alonso-Coello; Vicente Plaza
Journal:  Cochrane Database Syst Rev       Date:  2014-03-03

9.  A 12-week, Randomized, Parallel-group, Phase III Study Comparing the Efficacy of Once-daily Budesonide/formoterol Turbuhaler (160/4.5 μg/d) with Twice-daily Budesonide (400 μg/d) During the Step-down Period in Well-controlled Asthma.

Authors:  Narongwit Nakwan; Thitima Perkleang; Thanida Tamsawai; Pattarawadee Taptawee; Sirikade Usaha
Journal:  Turk Thorac J       Date:  2018-04-01

10.  Longitudinal validation of a tool for asthma self-monitoring.

Authors:  Flory L Nkoy; Bryan L Stone; Bernhard A Fassl; Derek A Uchida; Karmella Koopmeiners; Sarah Halbern; Eun H Kim; Allison Wilcox; Jian Ying; Tom H Greene; David M Mosen; Michael N Schatz; Christopher G Maloney
Journal:  Pediatrics       Date:  2013-11-11       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.